Drug Trial Radar · NCT00081458
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Last checked: Nov 19, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
May 25, 2004
Primary completion
Jul 6, 2007
Study completion Jul 6, 2007
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Apr 14, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS).
Conditions
- Short Bowel Syndrome
Interventions
PlaceboDrug
placebo injectable subcutaneously daily into thigh or abdomen
Teduglutide 0.05 mg/kg/dDrug
Teduglutide 0.05 mg/kg/d daily injectable subcutaneously into the thigh or abdomen
Teduglutide 0.1 mg/kg/dDrug
Teduglutide 0.1 /g/kg/d daily injection subcutaneously into thigh or abdomen
Primary outcomes
What the sponsor says the trial is designed to measure.
- A Graded Response Score in Parenteral Nutrition (PN) ReductionTime frame: 6 months
Locations
32 sites in 9 countries. Site status is shown where the registry gives one.
Mayo Clinic Scottsdale
Scottsdale, Arizona
Georgetown University
Washington D.C., District of Columbia
Emory University Hospital
Atlanta, Georgia
Northwestern Center for Clinical Research
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Nebraska Medical Center
Omaha, Nebraska
Albany Medical Center
Albany, New York
Mount Sinai School of Medicine
New York, New York
University of Rochester Medical Center
Rochester, New York
The Cleveland Clinic Foundation
Cleveland, Ohio
University of Pennsylvania - Penn Nursing
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
Medical University of South Carolina
Charleston, South Carolina
l'Hôpital Erasme
Brussels, Belgium
Royal Alexandra Hospital
Edmonton, Alberta, Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Hôpital Claude-Huriez
Lille, France
Hôpital de la Croix-Rousse
Lyon, France
Hôpital Edouard Herriot
Lyon, France
Hôpital Beaujon
Paris, France
Charité University Hospital
Berlin, Germany
Charité-Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Academic Medical Center
Amsterdam, Netherlands
Pracownia Żywienia Klinicznego
Olsztyn, Poland
Samodzielny Publiczny Szpital Kliniczny-Im.prof W.Orłowskiego CMKP
Warsaw, Poland
St. Mark's Hospital
Harrow, United Kingdom
Hope Hospital
Salford, Greater Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.